Life sciences may have received a boost from the global pandemic, and more recently from a £650m ‘war chest’ and package of measures revealed by chancellor Jeremy Hunt to encourage investment and development in the sector, but experts believe subtler events elsewhere could have a bigger influence on the sector’s property needs.
“The big shift has been science becoming more data-driven,” says James Sheppard, managing director for the UK and Ireland at specialist developer Kadans Science Partner. “The skillset required by big pharmaceuticals has changed. They now want data scientists, bioinformaticians and computer scientists to sit alongside traditional wet-lab roles.” Hunting for graduates with these emerging talents requires a fundamental employer rebranding for many companies.
Read more HERE
